Purpose: To compare pain relief among various dose-fractionation schedules of localized
radiotherapy (RT) in the treatment of painful bone metastases. Methods and Materials: A …

Purpose Interest in collecting patient-reported outcomes (PROs), such as health-related quality
of life (HRQOL), health status reports, and patient satisfaction is on the rise and practical …

Purpose To assess the patterns of, and trends over time in, health-related quality of life (HRQL)
reporting in randomized controlled trials (RCTs). Methods The English-language …

Background We conducted a randomized, placebo-controlled, double-blind trial to determine
whether the epidermal growth factor receptor inhibitor erlotinib prolongs survival in non–…

Context Patients with early stage but medically inoperable lung cancer have a poor rate of
primary tumor control (30%-40%) and a high rate of mortality (3-year survival, 20%-35%) with …

Background The COVID-19 pandemic has caused radiotherapy resource pressures and led
to increased risks for lung cancer patients and healthcare staff. An international group of …

Background Concurrent chemoradiotherapy is the standard of care in limited-stage small-cell
lung cancer, but the optimal radiotherapy schedule and dose remains controversial. The …

Purpose This report describes the quality of life (QOL) findings of a randomized placebo
controlled study of erlotinib, an epidermal growth factor receptor inhibitor, in patients with non–…

Purpose: Cone-beam computed tomography (CBCT) in-room imaging allows accurate inter-
and intrafraction target localization in stereotactic body radiotherapy of lung tumors. …

Purpose: Solitary plasmacytoma (SP) is a rare presentation of plasma cell neoplasms. In
contrast to multiple myeloma, long-term disease-free survival and cure is possible following …